Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;12(17-18):777-85.
doi: 10.1016/j.drudis.2007.07.013. Epub 2007 Aug 22.

The Significance of Mitochondrial Toxicity Testing in Drug Development

Affiliations
Review

The Significance of Mitochondrial Toxicity Testing in Drug Development

James A Dykens et al. Drug Discov Today. .

Abstract

Mitochondrial dysfunction is increasingly implicated in the etiology of drug-induced toxicities. Members of diverse drug classes undermine mitochondrial function, and among the most potent are drugs that have been withdrawn from the market, or have received Black Box warnings from the FDA. To avoid mitochondrial liabilities, routine screens need to be positioned within the drug-development process. Assays for mitochondrial function, cell models that better report mitochondrial impairment, and new animal models that more faithfully reflect clinical manifestations of mitochondrial dysfunction are discussed in the context of how such data can reduce late stage attrition of drug candidates and can yield safer drugs in the future.

Similar articles

See all similar articles

Cited by 68 articles

See all "Cited by" articles

LinkOut - more resources

Feedback